Answer
No. The UK licence is limited to mild cognitive impairment and mild dementia due to Alzheimer’s disease.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.